The U.S. Cybersecurity and Infrastructure Security Agency (CISA) and the U.S. Food and Drug Administration (FDA) recently issued a joint warning about security vulnerabilities in the Contec CMS8000 patient monitoring device.
These vulnerabilities could allow unauthorized access to patient data, remote device manipulation, and protected health information (PHI) transmission to external entities.
The Contec CMS8000, a patient monitoring device used in hospitals and clinics to track vital signs, has been found to contain embedded functions with massive security risks. Healthcare organizations using the device must mitigate potential unauthorized access and assess whether breaches have already occurred.
Manufactured by Contec Medical Systems, a company in China, the CMS8000 is marketed in the United States, repackaged, and marketed by third-party resellers, also under the name ‘Epsimed MN-120’.
Ultimately, its extensive distribution further increases healthcare providers’ possible risk exposure.
The FDA and CISA identified three vulnerabilities in the Contec CMS8000:
According to the joint warning, the FDA makes the following recommendations for patients and caregivers:
Additionally, the FDA makes the following recommendations for healthcare providers:
The Health Insurance Portability and Accountability Act (HIPAA) mandates that covered entities safeguard individuals’ PHI. So, healthcare providers must verify that medical devices collecting PHI adhere to HIPAA’s Security Rule.
Moreover, unauthorized access to PHI, as seen in the Contec CMS8000 vulnerability, can result in HIPAA violations with severe consequences, including hefty fines and legal ramifications.
The increasing connectivity of medical devices introduces greater cybersecurity risks, including potential data breaches and unauthorized access to critical patient information. So, when healthcare organizations use medical devices, like Contec, they must conduct security audits, improve incident response planning, and adhere to FDA and CISA guidelines.
No, as of now, there is no available patch to fix the vulnerabilities.
HIPAA mandates safeguards such as encryption, access controls, risk assessments, and security monitoring.
Conduct an immediate investigation, notify affected patients, and report the breach to the appropriate regulatory authorities.
Go deeper: How to respond to a data breach